Prognosis of cancer of the pancreas;Die prognose des pankreaskarzinoms

Therapeutische Umschau

Volumn 53, Issue 5, 1996, Pages 401-407

  Friess, H ^a   Isenmann, R ^a   Berberat, P ^a   Kleeff, J ^a   Buchler M W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR;

BLOOD; CANCER STAGING; HUMAN; METHODOLOGY; PANCREAS RESECTION; PANCREAS TUMOR; PANCREATICODUODENECTOMY; PATHOLOGY; PROGNOSIS; REVIEW;

EPIDERMAL GROWTH FACTOR; HUMANS; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROGNOSIS; TRANSFORMING GROWTH FACTORS;

EID: 0030140071     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Warshaw A. L., Fernandez-Del Castillo C.: Pancreatic carcinoma. N. Engl. J. Med. 326, 455-465, 1992.
2. Fontham E., Correa P., Cohn I. Jr.: Epidemiology of cancer of the pancreas. In: Howard J. M., Jordan G. L., Reber H. A. (Hrsg.): Surgical diseases of the pancreas. Philadelphia: Lea and Febiger, 627-640, 1987.
3. Statistisches Bundesamt. Todesursachen in Deutschland 1992, Fachserie, 12, Reihe 4, 2, 1994.
4. Schölmerich J.: Diagnosis of Pancreatic Cancer. In Beger H. G., Büchler M., Malfertheiner P. (Eds.): Standards in Pancreatic Surgery, Springer Verlag Berlin, Heidelberg, New York, 578-590, 1993.
5. Ashley W. A., Reber H. A.: Surgical Management of Exocrine Pancreatic Cancer, In: Go V. L. W., Di Magno E. P., Gardner J. D., Lebenthal E., Reber H. A., Scheele G. A. (Hrsg.): The Pancreas, Raven Press, New York. 913-929, 1993.
6. Borman P. C., Krige J. C. J.: Prognosis in Carcinoma of the Pancreas. Dig. Surg. 11, 342-345, 1994.
7. 18F)-fluoro-2-deoxy-glucose positron emission tomography. GUT 36, 771-777, 1995.
8. Bakkevold K. E., Kambestad B.: Morbidity and Mortality After Radical and Palliative Pancreatic Cancer Surgery. Ann. Surg. 217, 356-368, 1993.
9. Pour P. M., Permerth J., Mogaki M.: Morphology of Pancreativ Exocrine Tumors. In Beger H. G., Büchler M., Malfertheiner P. (Eds.): Standards in Pancreatic Surgery, Springer Verlag Berlin, Heidelberg, New York, 567-572, 1993.
10. Warshaw A. L., Compton C. C., Lewandrowski K., Cardenosa G., Mueller P. R.: Cystic Tumors of the Pancreas. New Clinical, Radiologiv, and Pathologic Observations in 67 Patients. Ann. Surg. 222, 432-445, 1990.
11. Gudjonsson B.: Cancer of the pancreas. 50 years of surgery. Cancer 1987, 60, 2284-2303, 1987.
12. Shing S. M., Longmire W. P., Reber H. A.: Surgical palliation for pancreatic cancer. The UCLA experience. Ann. Surg. 212, 132-139, 1990.
13. Livingston E. H., Welton M. L., Reber H. A.: Surgical treatment of pancreatic cancer. The United States experience. Int. J. Pancreatol. 9, 153-157, 1991.
14. Grace P. A., Pitt H. A., Tompkins R. K.: Decreased morbidity and mortality after pancreaticoduodenectomy. Am. J. Surg. 151, 141-149, 1986.
15. Christ D. W., Sitzmann J. V., Cameron J. L.: Improved hospital morbidity, mortality, and survival after Whipple procedure. Ann. surg. 206, 358-365, 1987.
16. Trpde M., Schwall G., Saeger H.: Survival after pancreaticoduodenectomy. Ann. Surg. 211, 447-458, 1990.
17. Lygidakis N. J., van der Hyde M. N., Houthoff H. J.: Resectional surgical procedures for carcinoma of the head of the pancreas. Surg. Gynecol. Obstet. 168, 157-165, 1989.
18. Jordan G. L.: Pancreatic Resection for Pancreatic Cancer In: Surgical diseases of the pancreas. In: Howard J. M., Jordan G. L., Reber H. A. (Hrsg.): Surgical diseases of the pancreas. Philadelphia: Lea and Febiger, 666-713, 1987.
19. Friess H., Uhl W., Beger H. G., Büchler M. W.: Surgical treatment of pancreatic cancer. Dig. Surg. 11, 378-386, 1994.
20. Baer H. U., Wagner M., Büchler M. W.: Pancreatic Cancer: Indications for Surgery. Dig. Surg. 11. 372-377, 1994.
21. Friess H., Uhl W., Beger H. G., Büchler M. W.: Surgical Treatment of Pancreatic Cancer. Dig. Surg, 11, 378-386, 1994.
22. Nagai H., Kuroda A., Morioka Y.: Lymphatic and local spread of T1 & 2 pancreatic cancer. A study of autopsy material. Ann. Surg. 204, 65-71, 1986.
23. Kayahara M., Nagakawa T., Konshi I., Uneno K., Ohta T., Myazaki I.: Clinipathological study of pancreatic carcinoma with particular reference to the invasion of extrapancreatic neural plexus. Int. J. Pancreatol. 10, 105-111, 1991.
24. Büchler M., Friess H., Klempa I., Hermanek P., Sulkowsky U., Becker H., Schafmayer A., Baca I., Lorenz D., Meister R., Kremer B., Wagner P., Witte J., Zurmayer E. L., Saeger H-U., Rieck B., Dollinger P., Glaser K., Teichmann R., Konradt J., Gaus W., Dennler H-J., Welzel D., Reger H. G.: Role of Octreotide in the prevention of postoperative complications following pancreatic resection. Am. J. Surg. 163, 125-131, 1992.
25. Bartoli F. G., Arnone G. B., Ravera G., Bachi V.: Pancreatic Fistula and Relative Mortality in Malignant Disease after Pancreaticoduodenectomy. Review and Statistical Meta-Analysis Regarding 15 Years of Literature. Anticancer Res. 11, 1831-1848, 1991.
26. Roder J. D., Stein H. J., Hüttl W., Siewert J. R.: Pylorus-preserving versus standard pancreaticoduo-denectomy: An analysis of 110 pancreatic and periampullary carcinomas. Br. J. Surg. 79, 152-155, 1992.
27. Friess IL, Korc M., Berberat P., Büchler M. W.: Potential clinical relevance of alterations in growth factors and their receptors. J. Mol. Med., im Druck, 1996.
28. Korc M., Chandrasekar B., Yamanaka Y., Friess H., Büchler M. W., Beger H. G.: Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha. J. Clin. Invest. 1352-1360, 1992.
29. Yamanaka Y., Friess H., Büchler M. W., Kobrin M. S., Beger H. G., Korc M.: Coexpression of epidermal growth factor receptor and ligands is associated with enhanced aggressiveness of human pancreatic cancer. Anticancer Res. 13, 563-570, 1993.
30. Yamanaka Y., Friess H., Büchler M. W., Kobrin M. S., Kunz J., Beger H. G., Korc M.: Overexpression of HER2/neu oncogene in human pancreatic carcinoma. Human Pathol., 24, 1127-1134, 1993.
31. Friess H., Yamanaka Y., Kobrin M. S., Do A. D., Büchler M. W., Korc M.: Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression. Clni. Cancer Res. 1, 1413-1420, 1995.
32. Kobrin M. S., Yamanaka Y., Friess H., Lopez M. E., Korc M.: Aberrant expression of the type I fibroblast growth factor receptor in human pancreatic adenocarcinomas. Cancer Res. 53, 4741-4744, 1993.
33. Friess H., Yamanaka Y., Büchler M. W., Berger H. G., Kobrin M. S., Baldwin R. L., Korc M.: Enhanced expression of the type II transforming growth factor-beta receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res. 53, 2704-2707, 1993.
34. Ebert M., Yokoyama M., Friess II., Büchler M. W., Korc M.: Coexpression of the c-met protooncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res. 54, 5775-5778, 1994.
35. Yokoyama M., Ebert M., Funatomi H., Friess H., Büchler M. W., Johnson G. R., Korc M.: Amphiregulin is a potent mitogen in human pancreatic cancer cells: correlation with patients survival. Int. J. Oncol. 6, 625-631, 1995.
36. Yokoyama M., Funatomi H., Kobrin M. S., Ebert M., Friess H., Büchler M. W., Korc M.: Betacellulin, a member of the epidermal growth factor family, is overexpressed in human pancreatic cancer. Int. J. Oncology 7, 825-829, 1995.
37. Kobrin M. S., Funatomi H., Friess H., Büchler M. W., Stathis P., Korc M.: Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem. and Biophys. Res. Commun. 202, 1705-1709, 1994.
38. Yamanaka Y., Friess H., Büchler M. W., Beger H. G., Uchida E., Masahiko O., Kobrin M.S., Korc M.: Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer. Res. 53, 5289-5296, 1993.
39. Friess H., Yamanaka Y., Büchler M. W., Ebert M., Beger H. G., Gold L. L, Korc M.: Enhanced expression of transforming growth factor-beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105, 1846-1856, 1993.
40. Hanyu F., Suzuki M., Imaizumi T.: Whipple Operation for Pancreatic Carcinoma: Japanese Experience. In: Beger H. G., Büchler M., Malfertheiner P. (Eds.): Standards in Pancreatic Surgery, Springer Verlag Berlin. Heidelberg, New York S. 646-653, 1993.
41. Tsuchiya R., Noda T., Harade N., Miyamoto T., Tomioka T., Yamamoto K., Yamaguchi T., Izawa K., Tsunoda T., Yoshino R., Eto T.: Collective review of small carcinomas of the pancreas. Ann. Surg. 203, 77-81, 1986.
42. Cameron J. L., Crist D. W., Sitzmann J. V., Hruban R. H., Botnott J. K., Seidler A. J., Coleman J.: Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am. J. Surg. 161, 120-125, 1991.
43. Gall F. P., Kessler H., Hermanek P.: Surgical treatment of ductal pancreatic carcinoma. Eur. J. Surg. Oncol. 211, 447-458, 1991.